📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria. (2020)

First Author: Kiga K

Attributed to: Translational Research Initiative funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-020-16731-6

PubMed Identifier: 32523110

Publication URI: http://europepmc.org/abstract/MED/32523110

Type: Journal Article/Review

Volume: 11

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723